The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 722.00
Bid: 720.00
Ask: 728.00
Change: 2.00 (0.28%)
Spread: 8.00 (1.111%)
Open: 758.00
High: 758.00
Low: 722.00
Prev. Close: 720.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

19 Mar 2020 07:00

RNS Number : 7068G
discoverIE Group plc
19 March 2020
 

For Release

7.00am, 19 March 2020

 

discoverIE Group plc

Year End Trading Update

 

 

discoverIE Group plc (LSE: DSCV, "discoverIE" or the "Group"), a leading international designer, manufacturer and supplier of customised electronics to industry, today issues a trading update for the year ending 31 March 2020.

Following strong momentum through the year, during the fourth quarter the Group has experienced some isolated disruption to the business as a result of the outbreak of the COVID-19 virus.

In China, the Group operates two manufacturing facilities in Guangdong province, and also has a number of Chinese suppliers and customers. Following an extended shut down after the Chinese New Year, the facilities are again operational, with production returning to planned levels. Similarly, our Chinese suppliers have recommenced operations and sales to our customers are returning to normal levels, with demand recovering quickly.

The Group's Design & Manufacturing division operates a diversified and flexible manufacturing footprint with additional facilities in India, Sri Lanka, Thailand, South Korea, Poland, Slovakia, the Netherlands, Belgium, UK, Germany, the Nordic region, Mexico, US and Canada, all of which are currently operating without major disruption. With the wellbeing of our employees being a priority and following local regulatory guidance, discoverIE's diversified businesses all have detailed business continuity plans and are maintaining operational continuity.

Aside from the Chinese disruption described above, trading elsewhere in the Group during the fourth quarter has been in line with our expectations, against a strong comparative period in the prior year, as we continue to benefit from the focus on our target markets. As a result, the disruption during the fourth quarter is expected to have a modest impact on our earnings for the year to 31 March 2020.

The Group benefits from a strong and diversified customer base, and demand remains robust with good new order intake in March. Whilst the Group is well prepared to respond quickly and effectively to mitigate any further disruption from the spread of COVID-19, the wider potential impacts entering the new financial year are difficult to predict. The Group remains well funded, with a strong balance sheet, good cash liquidity, over £100m of headroom against its debt facilities and gearing1 of 1.5x.

We are confident that our clear strategy focusing on the target markets of renewable energy, medical, transportation and industrial & connectivity to create sustainable organic growth will enable us to continue to outperform wider industrial markets and generate significant stakeholder value.

 

For further information, please contact:

 

discoverIE Group plc

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

 

Instinctif

Mark Garraway

James Gray

01483 544 500

 

 

 

 

020 7457 2020

 

 

Notes

1. Gearing defined as net debt divided by underlying EBITDA, annualised for acquisitions.

 

2. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of discoverIE Group plc. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this update. Forward looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

3. The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation, Article 7 of EU Regulation 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Notes to Editors:

 

About discoverIE Group plc

 

discoverIE Group plc is an international group of businesses that designs, manufactures and supplies innovative components for electronic applications.

 

The Group provides application-specific components to original equipment manufacturers ("OEMs") internationally. By designing components that meet customers' unique requirements, which are then manufactured and supplied throughout the life of their production, a high level of repeating revenue is generated with long term customer relationships.

 

By focusing on key markets driven by structural growth and increasing electronic content, namely renewable energy, transportation, medical and industrial & connectivity, the Group aims to achieve organic growth that is well ahead of GDP and to supplement that with targeted complementary acquisitions.

 

The Group employs c.4,500 people and its principal operating units are located in Continental Europe, the UK, China, Sri Lanka, India and North America.

 

The Group is listed on the Main Market of the London Stock Exchange and is in the top quartile of the FTSE Small Cap Index, classified within the Electrical Components and Equipment subsector, and has revenues of over £400m. Over the last five years, revenue and underlying earnings per share have both more than doubled.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFFFAAESSEED
Date   Source Headline
30th Jun 20206:00 pmRNSHolding(s) in Company
30th Jun 20208:00 amRNSHolding(s) in Company
24th Jun 20207:00 amRNSFinal Results
3rd Jun 20201:24 pmRNSHolding(s) in Company
15th May 20207:00 amRNSYear-end & Covid-19 Trading Update
14th May 20204:05 pmRNSDirector Declaration
21st Apr 20201:00 pmRNSDirector Declaration
14th Apr 202010:19 amRNSHolding(s) in Company
9th Apr 202012:35 pmRNSHolding(s) in Company
7th Apr 20201:45 pmRNSIssue of Equity & Total Voting Rights
20th Mar 20204:42 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSYear End Trading Update
11th Mar 20203:04 pmRNSHolding(s) in Company
11th Mar 20201:49 pmRNSDirector/PDMR transaction notification
19th Feb 20207:03 amRNSDirector Declaration
30th Jan 20207:00 amRNSThird Quarter Trading Update
23rd Jan 20208:59 amRNSHolding(s) in Company
16th Jan 202010:57 amRNSHolding(s) in Company
23rd Dec 20199:26 amRNSHolding(s) in Company
9th Dec 20198:42 amRNSHolding(s) in Company
28th Nov 20197:00 amRNSHalf-year Report
19th Nov 20192:58 pmRNSDirector Declaration
23rd Oct 201910:44 amRNSHolding(s) in Company
23rd Oct 20199:01 amRNSHolding(s) in Company
17th Oct 20191:15 pmRNSResults of Placing
17th Oct 20197:00 amRNSAcquisition & Proposed Placing
10th Oct 20197:00 amRNSTrading Update
2nd Sep 20197:00 amRNSDirector Declaration
25th Jul 20191:38 pmRNSResult of AGM
25th Jul 20197:00 amRNSTrading Update
24th Jul 20199:00 amRNSIssue of Equity
10th Jul 201911:40 amRNSHolding(s) in Company
25th Jun 201911:31 amRNSAnnual Report and Accounts
4th Jun 20197:00 amRNSFinal Results
3rd May 20192:48 pmRNSHolding(s) in Company
1st May 20194:21 pmRNSDirector LTIP Award
30th Apr 20199:00 amRNSDirectorate Change
24th Apr 201911:21 amRNSHolding(s) in Company
18th Apr 201911:57 amRNSDirector/PDMR Shareholding
16th Apr 20191:08 pmRNSDirector Declaration
16th Apr 201911:35 amRNSResults of Placing
16th Apr 20197:01 amRNSAcquisitions & Proposed Placing
16th Apr 20197:00 amRNSTrading Update
18th Mar 20192:52 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSBoard and Committee Changes
8th Feb 20199:22 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSThird Quarter Trading Update
5th Dec 201810:12 amRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.